The Role of AI in Osteosarcoma Pathology and Radiology
In 2026, Artificial Intelligence (AI) has become a standard tool in the US diagnostic process
. AI-powered software is used by radiologists to detect tiny lung metastases on CT scans that might be missed by the human eye. In pathology labs, AI algorithms analyze biopsy slides to calculate the exact percentage of tumor necrosis following chemotherapy, providing a more objective and faster prognosis than traditional manual counting. This "Computational Oncology" allows for more rapid adjustments to treatment plans, ensuring that patients who are not responding to standard therapy can be moved to clinical trials sooner.
















